Search research articles
Contact Us
Filters
Showing results (251-260 of 419) with videos related to
Page
of 42
Sort By:
Cancer Medicine
|
November 2, 2021
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration
Stephen J Freedland, Rickard Sandin, Janvi Sah, et al.
FEBS Letters
|
November 24, 1999
Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization
K Sakamoto, Y Yamasaki, H Kaneto, et al.
No to Shinkei = Brain and Nerve
|
July 1, 1992
[Perinatal neurosurgical care for one fetal hydrocephalus on twin gestation]
K Nishikuni, K Morimoto, A Wakayama, et al.
Archives of Toxicology
|
October 9, 1998
Serum and urinary boron levels in rats after single administration of sodium tetraborate
K Usuda, K Kono, Y Orita, et al.
No to Hattatsu = Brain and Development
|
July 1, 1989
[Ultrasonic Doppler assessment of hemodynamics in extra-intracranial arterial anastomosis in children with Moyamoya disease]
T Tagawa, Y Itagaki, T Mimaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Challenges in recognizing treatment-related neuroendocrine prostate cancer
Himisha Beltran, Scott T Tagawa, Kyung Park, et al.
Prostate Cancer and Prostatic Diseases
|
July 15, 2022
Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2022
Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
Investigational New Drugs
|
July 26, 2012
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
Gary Hudes, Scott T Tagawa, Young E Whang, et al.
Current Radiopharmaceuticals
|
March 16, 2015
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S Jhanwar, et al.
Page
of 42
Search research articles
Search
Showing results (251-260 of 419) with videos related to
Sort By:
Page
of 42
Cancer Medicine
|
November 2, 2021
Treatment patterns and survival in metastatic castration-sensitive prostate cancer in the US Veterans Health Administration
Stephen J Freedland, Rickard Sandin, Janvi Sah, et al.
FEBS Letters
|
November 24, 1999
Identification of oxidative stress-regulated genes in rat aortic smooth muscle cells by suppression subtractive hybridization
K Sakamoto, Y Yamasaki, H Kaneto, et al.
No to Shinkei = Brain and Nerve
|
July 1, 1992
[Perinatal neurosurgical care for one fetal hydrocephalus on twin gestation]
K Nishikuni, K Morimoto, A Wakayama, et al.
Archives of Toxicology
|
October 9, 1998
Serum and urinary boron levels in rats after single administration of sodium tetraborate
K Usuda, K Kono, Y Orita, et al.
No to Hattatsu = Brain and Development
|
July 1, 1989
[Ultrasonic Doppler assessment of hemodynamics in extra-intracranial arterial anastomosis in children with Moyamoya disease]
T Tagawa, Y Itagaki, T Mimaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 22, 2012
Challenges in recognizing treatment-related neuroendocrine prostate cancer
Himisha Beltran, Scott T Tagawa, Kyung Park, et al.
Prostate Cancer and Prostatic Diseases
|
July 15, 2022
Correction: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
Prostate Cancer and Prostatic Diseases
|
January 18, 2022
Correction to: Survival outcomes in patients with chemotherapy-naive metastatic castration-resistant prostate cancer treated with enzalutamide or abiraterone acetate
Scott T Tagawa, Krishnan Ramaswamy, Ahong Huang, et al.
Investigational New Drugs
|
July 26, 2012
A phase 1 study of a chimeric monoclonal antibody against interleukin-6, siltuximab, combined with docetaxel in patients with metastatic castration-resistant prostate cancer
Gary Hudes, Scott T Tagawa, Young E Whang, et al.
Current Radiopharmaceuticals
|
March 16, 2015
Radioimmunotherapy of Metastatic Prostate Cancer with ¹⁷⁷Lu-DOTAhuJ591 Anti Prostate Specific Membrane Antigen Specific Monoclonal Antibody
Shankar Vallabhajosula, Anastasia Nikolopoulou, Yuliya S Jhanwar, et al.
Page
of 42